PubRank

The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28537931)

Published in Oncotarget on May 09, 2017

Authors

Eun-Jin Yun1, Jiancheng Zhou1,2, Chun-Jung Lin1, Shan Xu1,3, John Santoyo1, Elizabeth Hernandez1, Chih-Ho Lai4, Ho Lin5, Dalin He3, Jer-Tsong Hsieh1,6

Author Affiliations

1: Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
2: Department of Urology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, China.
3: Department of Urology, The First Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an 710049, China.
4: Department of Microbiology and Immunology, Chang Gung University, Taoyuan 333, Taiwan.
5: Department of Life Sciences, national Chung Hsing University, Taichung 402, Taiwan.
6: Graduate Institute of Cancer Biology, China Medical University Hospital, Taichung 40447, Taiwan, Republic of China.

Articles by these authors ⇆

Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues. Oncotarget (2016) 0.77

Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs. Cell Death Dis (2017) 0.75

The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes. Oncotarget (2017) 0.75